Skip to main content

Peer Review reports

From: Antitumor activity of the protein kinase inhibitor 1-(β-D-2′-deoxyribofuranosyl)-4,5,6,7-tetrabromo- 1H-benzimidazole in breast cancer cell lines

Original Submission
27 May 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
13 Jul 2022 Reviewed Reviewer Report
17 Jul 2022 Reviewed Reviewer Report
5 Sep 2022 Author responded Author comments - Mirosława Koronkiewicz
Resubmission - Version 3
5 Sep 2022 Submitted Manuscript version 3
13 Sep 2022 Author responded Author comments - Mirosława Koronkiewicz
Resubmission - Version 4
13 Sep 2022 Submitted Manuscript version 4
20 Sep 2022 Reviewed Reviewer Report
21 Sep 2022 Reviewed Reviewer Report
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
29 Sep 2022 Editorially accepted
15 Oct 2022 Article published 10.1186/s12885-022-10156-8

You can find further information about peer review here.

Back to article page